Intelligene

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.intelli-gene.com

Country

Taiwan

Exchange

Taipei Exchange

Founded 2023

Intelligene provides the research and development of RNA gene therapy drugs in Taiwan and Australia. The company offers IG-001, a siRNA-based drug which is under preclinical trials for the treatment of coronavirus disease; and IG-002, a siRNA-based drug which is under drug screening for the treatment of influenza

Lipid nanoparticle and exosome drug encapsulation technologies to customize drug carriers and develop nucleic acid therapeutics. Founded in 2023, the company is based in Taipei, Taiwan.

Key Stats

52-Week Range

NT$9.37NT$17.65

BetaN/A

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-0.26

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.